About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Novel Coronavirus Well-adapted to Humans, Susceptible to Immunotherapy: Study

by Rukmani Krishna on February 22, 2013 at 10:01 PM
Font : A-A+

 Novel Coronavirus Well-adapted to Humans, Susceptible to Immunotherapy: Study

According to a study the new coronavirus that has emerged in the Middle East is well-adapted to infecting humans but could potentially be treated with immunotherapy. The study was published on February 19 in mBioŽ, the online open-access journal of the American Society for Microbiology. The study indicates that the virus HCoV-EMC can penetrate the lining of the passageways in the lung and evade the innate immune system as easily as a cold virus can, signs that HCoV-EMC is well-equipped for infecting human cells. The study also reveals that the virus is susceptible to treatment with interferons, components of the immune system that have been used successfully to treat other viral diseases, opening a possible mode of treatment in the event of a large-scale outbreak.

"Surprisingly, this coronavirus grows very efficiently on human epithelial cells," says co-author Volker Thiel of The Institute of Immunobiology at Kantonal Hospital in St. Gallen, Switzerland. Thiel says these new data indicate that although HCoV-EMC may have jumped from animals to humans very recently, it is just as well adapted to infecting the human respiratory tract as other, more familiar human coronaviruses, including the SARS virus and the common cold virus, HCoV-229E.

Advertisement

HCoV-EMC first came to light in June when it was isolated from a man in Saudi Arabia who died from a severe respiratory infection and kidney failure. Since that time, public health officials have identified an additional 10 infected persons, nine of whom had traveled in the Middle East and one who had recent contact with an infected person. The emergence of HCoV-EMC, which is related to the SARS virus, has raised concern that it may eventually lead to a pandemic much like the SARS pandemic of 2002-2003, which is estimated to have sickened over 8,000 people and killed 774 worldwide.

For the mBioŽ study, Thiel and his colleagues tested how well HCoV-EMC could infect and multiply in the entryways to the human lung using cultured bronchial cells manipulated to mimic the airway lining. The lining of the lung, or epithelium, represents an important first barrier against respiratory viruses, but they apparently don't put up a big fight against HCoV-EMC, says Thiel. He and his colleagues found that human airway epithelial cells are highly susceptible to HCoV-EMC infection and that the virus is able to multiply at a faster initial rate than the SARS virus.
Advertisement

"The other thing we found is that the viruses [HCoV-EMC, SARS, and the common cold virus] are all similar in terms of host responses: they don't provoke a huge innate immune response," Thiel says. This is an indication that HCoV-EMC is already well adapted to the human host and that the virus uses that same strategy other coronaviruses use for evading the host's non-specific immune mechanisms.

The authors asked themselves whether boosting this weak immune response might diminish the virus' ability to infect airway epithelial cells. They found that pre-treating the cells with lambda-type interferons, proteins that are released by host cells in response to infection and enable communication between cells to mount an immune response, significantly reduced the number of infected cells. This is encouraging from a treatment standpoint, note the authors, since interferons have also shown a good deal of promise for treating SARS and another viral illness, Hepatitis C.

Thiel and co-author Ronald Dijkman emphasize that their work with HCoV-EMC would not have been possible without the efforts of many different research groups from Switzerland, Germany, The Netherlands, and Denmark.

Ongoing collaboration is crucial, they say. Future research to head off outbreaks of HCoV-EMC and other emerging diseases requires cooperation and trust among scientists and health agencies, a goal that is not always achieved. The future of this virus is uncertain, Thiel points out, but access to samples from a wider range of patients and epidemiological work could answer some fundamental questions, including where the virus is coming from and what the true prevalence of the virus is.

"We don't know whether the cases we observe are the tip of the iceberg," says Thiel. "Or whether many more people are infected without showing severe symptoms."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Middle East Respiratory Syndrome Coronavirus Indian Namaste the Preferred Greeting over Conventional Handshake COVID in Children COVID Vaccination for Pregnant Women COVID-19 Vaccine: Myths and Facts Mental Health during COVID-19: Top Tips to Manage COVID Anxiety, Depression How to Find Joy and Hope during COVID Times 

Recommended Reading
New Strain of Coronavirus can Infect Humans and Bats Alike
A new study published in the journal mBio reveals that public health authorities are worried over a ...
New Case of Coronavirus Reported in Saudi Arabia
In Saudi Arabia, a new case of coronavirus has been detected. The infected patient was cured after ....
New Live Vaccine Approach for SARS and Novel Coronaviruses Discovered
University of North Carolina and Vanderbilt University researchers have identified a novel live ......
New Coronavirus Linked to Bats
A new strain of the deadly Severe Acute Respiratory Syndrome (SARS) virus has been closely related ....
Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-n...
COVID in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID ...
COVID Vaccination for Pregnant Women
The Indian Government has approved Covid-19 vaccination of pregnant women, who are to be counselled ...
COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is importan...
How to Find Joy and Hope during COVID Times
Covid-19 has affected many physically, mentally and emotionally. Finding ways to maintain well-being...
Indian Namaste the Preferred Greeting over Conventional Handshake
COVID-19 pandemic is causing changes in how we greet each other. The traditional Indian way of greet...
Mental Health during COVID-19: Top Tips to Manage COVID Anxiety, Depression
Coping with mental health during COVID-19 is the need of the hour. The article highlights top tips t...
Middle East Respiratory Syndrome
MERS, a newly discovered respiratory disease, was recently reported in the Arabian region. MERS is c...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use